Loading financial statements…
Import this data to Google Sheets with:
=jivedata("PGOL","financials")Full statements spill as a table. For one cell: =jivedata("PGOL","Revenue") or =jivedata("PGOL","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
PGOL • CIK 0001080448
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenues | $1,930.348 | $361.523 | $0 | $1,777.84 |
| Nonoperating Income (Expense) | $7.938 | $28.422 | $18.409 | $1.769 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $66.979 | $-2,090.619 | $-1,879.452 | $-1,879.452 |
| Income Tax Expense (Benefit) | $-16 | $1,059 | $0 | $0 |
| Net Income (Loss) Attributable to Parent | $82.979 | $-3,149.619 | $-1,879.452 | $107.08 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $83.632 | $-3,148.886 | $-1,885.142 | $108.543 |
| Exploration Costs, Period Cost | $426.265 | $369.654 | $85.451 | $70.564 |
| Professional and Contract Services Expense | $688.859 | $486.3 | $355.127 | $311.138 |
| Noninterest Expense Directors Fees | $210 | $210 | $210 | $210 |
| General and Administrative Expense | $546.183 | $1,414.61 | $1,247.283 | $1,080.827 |
| Operating Expenses | $1,871.307 | $2,480.564 | $1,897.861 | $1,672.529 |
| Operating Income (Loss) | $59.041 | $-2,119.041 | $-1,897.861 | $105.311 |
| — | — | $8.384 | $45.643 | |
| Marketable Securities, Unrealized Gain (Loss) | — | $-10.718 | $30.363 | $24.842 |
| Foreign Currency Transaction Gain (Loss), before Tax | $-4.223 | $-2.308 | $-3.967 | $22.42 |
| Other Nonoperating Income | $16.241 | $41.448 | $0.397 | $0.15 |
| Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax | $-0.653 | $-0.733 | $5.69 | $-1.463 |
| Weighted Average Number of Shares Outstanding, Basic | 73,417,127 | 60,941,971 | 61,210,703 | 69,152,654 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Assets, Current | $2,254.041 | $531.035 | $179.103 | $981.663 |
| Assets, Noncurrent | $1,059 | $0 | $0 | $0 |
| Assets | $3,313.041 | $531.035 | $179.103 | $981.663 |
| Liabilities, Current | $278.065 | $738.305 | $2,027.613 | $1,813.649 |
| Stockholders' Equity Attributable to Parent | $3,034.976 | $-207.27 | $-1,848.51 | $-831.986 |
| Cash | $1,701.72 | $401.207 | $57.294 | $573.666 |
| Marketable Securities, Current | $32.237 | $22.082 | $52.445 | $54.101 |
| Advance Royalties, Current | $358.645 | $0 | $0 | $302.228 |
| Prepaid Expense, Current | $161.439 | $107.746 | $69.364 | $51.668 |
| Accounts Payable and Accrued Liabilities, Current | $39.229 | $458.305 | $873.518 | $257.931 |
| Other Accounts Payable and Accrued Liabilities | $238.836 | $280 | $490 | $605.272 |
| Common Stock, Value, Issued | $69.355 | $60.355 | $68.297 | $68.297 |
| Treasury Stock, Common, Value | $9.093 | $9.093 | $9.093 | $9.093 |
| Additional Paid in Capital | $28,200.259 | $28,115.899 | $28,374.259 | $28,374.259 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-15.414 | $-14.681 | $-20.371 | $-15.343 |
| Retained Earnings (Accumulated Deficit) | $-25,232.821 | $-28,382.44 | $-30,261.892 | $-29,250.396 |
| Common Stock, Shares Authorized | 400,000,000 | 400,000,000 | 400,000,000 | 400,000,000 |
| Common Stock, Shares, Issued | 69,354,539 | 60,354,539 | 68,296,490 | 68,296,490 |
| Treasury Stock, Common, Shares | 100,000 | 100,000 | 100,000 | 100,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | $-3,149.619 | $-1,879.452 | $107.08 |
| Accounts Receivable, Credit Loss Expense (Reversal) | — | $720.168 | $0 | $0 |
| Net Cash Provided by (Used in) Investing Activities | $0 | $0 | $0 | $0 |
| Proceeds from Convertible Debt | — | — | $664.095 | $950.446 |
| Payments for Repurchase of Equity | — | $93.36 | $0 | $0 |
| Net Cash Provided by (Used in) Financing Activities | $-1,038.853 | $-93.36 | $664.095 | $950.446 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $0.653 | $0.733 | $-5.69 | $1.462 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-455.616 | $-1,300.513 | $-343.913 | $452.07 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1,701.72 | $401.207 | $57.294 | $-190.316 |
| Unrealized Gain (Loss) on Investments | — | $-10.155 | $30.363 | $24.842 |
| Increase (Decrease) in Other Receivables | $-445.238 | $361.523 | $0 | $302.228 |
| Increase (Decrease) in Prepaid Expense | $-10.863 | $-53.693 | $-38.382 | $-11.888 |
| Increase (Decrease) in Income Taxes | $-16 | $1,059 | $0 | $0 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $9.976 | $419.076 | $415.213 | $-755.91 |
| Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | $45.661 | $41.164 | $210 | $220.272 |
| Net Cash Provided by (Used in) Operating Activities | $582.584 | $-1,207.886 | $-1,002.318 | $-499.838 |